The Longitude Prize on AMR is a £10m prize fund, with an £8m pay-out, that will reward a team of innovators who develop a point–of–care diagnostic test that will conserve antibiotics for future generations. The test must be accurate, rapid, affordable and easy to use anywhere in the world.

The Longitude Prize on AMR closed for applications on 30 September 2022. Final entries are now undergoing assessment by the Prize Advisory Panel.

If the panel believes that a submission meets the prize criteria as detailed in the Longitude Prize on AMR rules (revised April 2022), they will be invited for an interview with a sub-group of the Prize Advisory Panel to interrogate the evidence provided by the team.

Following  the interview, the panel may recommend that a potential winning diagnostic test undergoes additional independent testing to validate the claims about its efficacy. If a test undergoes independent testing, this process would take no longer than 12 months.

Results of the independent testing would be provided to the Prize Advisory Panel. The panel will then determine whether it is able to make a recommendation to the Longitude Prize Committee as to who should be named the winner of the prize.